Back to Peptides

Bronchogen

Moderate Research

AEDL Tetrapeptide | Bronchial Bioregulator

Dose 10-20 mg oral or 10 mg injectable
Frequency Daily for 10-20 days per cycle
Cycle 10-20 days
Storage Oral capsules: room temperature. Injectable: 2-8°C refrigerated

Bronchogen is a Khavinson bioregulator tetrapeptide (AEDL) with primary effects on the bronchopulmonary system. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson, it targets bronchial tissue and supports respiratory function. Like other Khavinson peptides, Bronchogen penetrates cell nuclei to influence gene expression related to respiratory tissue maintenance and repair.

Mechanism of Action

Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthesis in bronchopulmonary cells, supporting maintenance and repair of respiratory epithelium. The tetrapeptide structure allows efficient cellular uptake and tissue-specific targeting to bronchial structures.

Key Benefits

  • Supports bronchial tissue function
  • Regulates protein synthesis in lungs
  • Targets bronchopulmonary system
  • Maintains respiratory epithelium
  • Part of Khavinson bioregulator family
  • Epigenetic mechanism of action
  • Tissue-specific targeting
  • Well-tolerated in research
Molecular Weight
432 Da
Chain Length
4 amino acids
Type
Tetrapeptide bioregulator
Amino Acid Sequence
One-letter: AEDL
H₂N
A 1
O ‖ C
N
E 2
O ‖ C
N
D 3
O ‖ C
N
L 4
COOH
Ala
1

Alanine

Position 1

Glu
2

Glutamic Acid

Position 2

Asp
3

Aspartic Acid

Position 3

Leu
4

Leucine

Position 4

N-terminus C-terminus
Hydrophobic
Polar
Positive (+)
Negative (-)
Modified

Respiratory Support

  • Bronchial Function

    Supports bronchial tissue through gene expression regulation.

  • Respiratory Maintenance

    Helps maintain respiratory epithelium health.

  • Pulmonary Health

    Regulates protein synthesis in lung tissue.

Anti-Aging

  • Respiratory Aging

    Addresses age-related changes in bronchial tissue.

  • Gene Expression

    Modulates gene expression in respiratory cells.

Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles.

GoalDoseFrequencyRoute
Standard protocol10-20 mgDaily for 10-20 daysOral capsules
Maintenance10 mg2-3 cycles yearlyOral capsules
Chonluten

Related respiratory bioregulators; complementary mechanisms.

synergistic
Epitalon

Often combined in comprehensive anti-aging Khavinson protocols.

synergistic
Crystagen

Both have immune-modulating properties; different tissue targets.

compatible
Vilon

Part of Khavinson bioregulator family; targets different tissue.

compatible
During cycle

Gene expression modulation begins

Post-cycle

Effects persist due to epigenetic changes

Weeks-Months

Respiratory function improvements

Long-term

Cumulative benefits with periodic cycles

Common Side Effects

  • Generally well-tolerated
  • Minimal side effects reported

Stop Signs - Discontinue if:

  • Allergic reactions
  • Unusual respiratory symptoms

Contraindications

  • Active respiratory emergencies (seek medical care)
  • Known hypersensitivity
  • Pregnancy or breastfeeding

Good Signs

  • White powder or capsules
  • Clear solution if reconstituted
  • Proper packaging and labeling

Warning Signs

  • Unknown source or purity

Bad Signs

  • Discoloration
  • Unusual odor
  • Damaged packaging
  • Khavinson Peptide Bioregulators
    Advances in Gerontology (2020)

    Comprehensive review of bioregulator peptides including respiratory bioregulators.

  • Short Peptides and Bronchial Function
    Bulletin of Experimental Biology and Medicine (2018)

    Tetrapeptides derived from bronchial tissue regulate protein synthesis in respiratory cells.

  • Bioregulator Peptides and Respiratory Health
    Cell Technologies in Biology and Medicine (2016)

    Short peptides support bronchopulmonary system through epigenetic mechanisms.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.